These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 18207320)
1. N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells. Yan X; Chua MS; Sun H; So S Cancer Lett; 2008 Apr; 262(1):133-42. PubMed ID: 18207320 [TBL] [Abstract][Full Text] [Related]
2. NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma. Cheng J; Xie HY; Xu X; Wu J; Wei X; Su R; Zhang W; Lv Z; Zheng S; Zhou L Cancer Lett; 2011 Nov; 310(1):35-45. PubMed ID: 21763068 [TBL] [Abstract][Full Text] [Related]
3. Hypoxia and retinoic acid-inducible NDRG1 expression is responsible for doxorubicin and retinoic acid resistance in hepatocellular carcinoma cells. Jung EU; Yoon JH; Lee YJ; Lee JH; Kim BH; Yu SJ; Myung SJ; Kim YJ; Lee HS Cancer Lett; 2010 Dec; 298(1):9-15. PubMed ID: 20573444 [TBL] [Abstract][Full Text] [Related]
4. [Experimental research of therapeutic effect on hepatocellular carcinoma of targeting SMYD3 gene inhibition by RNA interference]. Xu JY; Chen LB; Xu JY; Yang Z; Xu RH; Wei HY Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):481-4. PubMed ID: 16772086 [TBL] [Abstract][Full Text] [Related]
5. N-myc downstream regulated gene 1 (NDRG1)/Cap43 enhances portal vein invasion and intrahepatic metastasis in human hepatocellular carcinoma. Akiba J; Ogasawara S; Kawahara A; Nishida N; Sanada S; Moriya F; Kuwano M; Nakashima O; Yano H Oncol Rep; 2008 Dec; 20(6):1329-35. PubMed ID: 19020710 [TBL] [Abstract][Full Text] [Related]
6. TIP30 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells through up-regulation of N-cadherin. Jiang C; Pecha J; Hoshino I; Ankrapp D; Xiao H Cancer Res; 2007 Apr; 67(8):3574-82. PubMed ID: 17440068 [TBL] [Abstract][Full Text] [Related]
7. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2]. Xu JY; Chen LB; Xu JY; Yang Z; Wei HY; Xu RH Ai Zheng; 2006 May; 25(5):526-32. PubMed ID: 16687068 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo. Wang W; Wu F; Fang F; Tao Y; Yang L Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974 [TBL] [Abstract][Full Text] [Related]
9. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro]. Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881 [TBL] [Abstract][Full Text] [Related]
10. EphA1 receptor silencing by small interfering RNA has antiangiogenic and antitumor efficacy in hepatocellular carcinoma. Chen G; Wang Y; Zhou M; Shi H; Yu Z; Zhu Y; Yu F Oncol Rep; 2010 Feb; 23(2):563-70. PubMed ID: 20043122 [TBL] [Abstract][Full Text] [Related]
11. Identification of NDRG1-regulated genes associated with invasive potential in cervical and ovarian cancer cells. Zhao G; Chen J; Deng Y; Gao F; Zhu J; Feng Z; Lv X; Zhao Z Biochem Biophys Res Commun; 2011 Apr; 408(1):154-9. PubMed ID: 21463610 [TBL] [Abstract][Full Text] [Related]
12. N-myc downstream regulated gene 1 acts as a tumor suppressor in ovarian cancer. Wang B; Li J; Ye Z; Li Z; Wu X Oncol Rep; 2014 May; 31(5):2279-85. PubMed ID: 24626771 [TBL] [Abstract][Full Text] [Related]
13. [Knocking down osteopontin expression by specific siRNA reduces the in vitro invasiveness of human hepatocellular carcinoma cells]. Zhu XQ; Ye QH; Lei KF; Chen J; Qin LX Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):404-7. PubMed ID: 17152482 [TBL] [Abstract][Full Text] [Related]
14. CDC25A inhibition suppresses the growth and invasion of human hepatocellular carcinoma cells. Xu X; Yamamoto H; Liu G; Ito Y; Ngan CY; Kondo M; Nagano H; Dono K; Sekimoto M; Monden M Int J Mol Med; 2008 Feb; 21(2):145-52. PubMed ID: 18204780 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3. Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839 [TBL] [Abstract][Full Text] [Related]
16. ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma. Kang YH; Ji NY; Lee CI; Lee HG; Kim JW; Yeom YI; Kim DG; Yoon SK; Kim JW; Park PJ; Song EY Amino Acids; 2011 Mar; 40(3):1003-13. PubMed ID: 20821239 [TBL] [Abstract][Full Text] [Related]
17. Knock-down of hepatitis B virus X protein reduces the tumorigenicity of hepatocellular carcinoma cells. Chan DW; Ng IO J Pathol; 2006 Feb; 208(3):372-80. PubMed ID: 16353167 [TBL] [Abstract][Full Text] [Related]
18. The human LIS1 is downregulated in hepatocellular carcinoma and plays a tumor suppressor function. Xing Z; Tang X; Gao Y; Da L; Song H; Wang S; Tiollais P; Li T; Zhao M Biochem Biophys Res Commun; 2011 Jun; 409(2):193-9. PubMed ID: 21569763 [TBL] [Abstract][Full Text] [Related]
19. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China. Dong-Dong L; Xi-Ran Z Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194 [TBL] [Abstract][Full Text] [Related]
20. Regulation of human hepatocellular carcinoma cells by Spred2 and correlative studies on its mechanism. Ma XN; Liu XY; Yang YF; Xiao FJ; Li QF; Yan J; Zhang QW; Wang LS; Li XY; Wang H Biochem Biophys Res Commun; 2011 Jul; 410(4):803-8. PubMed ID: 21703232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]